Table 3.
Univariate and multivariate analysis for PFS.
| HR | 95% CI | p value | |
|---|---|---|---|
| Univariate analysis | |||
| Age, ≥60/<60 years | 0.781 | 0.355-1.718 | 0.5386 |
| Early AFP response, yes/no | 0.464 | 0.222-0.967 | 0.0404 |
| Baseline AFP, ≥400/<400 ng/ml | 1.414 | 0.681-2.935 | 0.3530 |
| Ascites, yes/no | 1.377 | 0.664-2.853 | 0.3897 |
| Cirrhosis, yes/no | 1.127 | 0.497-2.555 | 0.7746 |
| Maximum tumor diameter, ≥10/<10 cm | 0.420 | 0.143-1.235 | 0.1150 |
| Number of tumors, solitary/multiple | 0.793 | 0.332-1.893 | 0.6014 |
| Extrahepatic metastasis, yes/no | 1.585 | 0.633-3.972 | 0.3255 |
| Portal vein thrombosis, yes/no | 0.825 | 0.374-1.819 | 0.6338 |
| BCLC stage, B/C | 0.711 | 0.270-1.872 | 0.4903 |
| ECOG PS, 0/1 | 0.431 | 0.265-0.897 | 0.0398 |
| ALBI grade, 1/2 | 0.538 | 0.290-0.973 | 0.0462 |
| Child-Pugh class, A/B | 0.658 | 0.311-1.393 | 0.2742 |
| Multivariate analysis | |||
| Age, ≥60/<60 years | 0.535 | 0.191-1.499 | 0.2341 |
| Early AFP response, yes/no | 0.387 | 0.183-0.992 | 0.0154 |
| ECOG PS, 0/1 | 0.489 | 0.411-0.976 | 0.0132 |
| Extrahepatic metastasis, yes/no | 1.659 | 0.525-3.517 | 0.5271 |
| Portal vein thrombosis, yes/no | 1.059 | 0.437-2.324 | 0.6574 |
| ALBI grade, 1/2 | 0.457 | 0.269-0.963 | 0.0327 |
ALBI, albumin-bilirubin; AFP, alpha-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; CI, confidence interval; ECOG PS, Eastern Cooperative Oncology Group performance status; HR, hazard ratio.